Geneos Wealth Management Inc. trimmed its stake in Procter & Gamble Company (The) (NYSE:PG – Free Report) by 12.8% in the third quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 24,980 shares of the company’s stock after selling 3,667 shares during the quarter. Geneos Wealth Management Inc.’s holdings in Procter & Gamble were worth $3,838,000 at the end of the most recent reporting period.
A number of other institutional investors and hedge funds also recently made changes to their positions in the stock. Halbert Hargrove Global Advisors LLC acquired a new position in Procter & Gamble during the third quarter worth $25,000. Nova Wealth Management Inc. bought a new position in shares of Procter & Gamble in the 1st quarter valued at about $26,000. Signature Resources Capital Management LLC increased its stake in shares of Procter & Gamble by 67.9% during the 2nd quarter. Signature Resources Capital Management LLC now owns 178 shares of the company’s stock worth $28,000 after purchasing an additional 72 shares during the last quarter. Mid American Wealth Advisory Group Inc. bought a new stake in shares of Procter & Gamble in the 2nd quarter valued at about $34,000. Finally, RMG Wealth Management LLC acquired a new stake in Procter & Gamble in the 2nd quarter valued at about $37,000. Institutional investors own 65.77% of the company’s stock.
Wall Street Analysts Forecast Growth
A number of equities analysts have weighed in on PG shares. Jefferies Financial Group raised Procter & Gamble from a “hold” rating to a “buy” rating and boosted their price target for the stock from $156.00 to $179.00 in a research report on Tuesday, December 16th. Berenberg Bank lifted their target price on Procter & Gamble from $152.00 to $154.00 and gave the stock a “hold” rating in a research note on Wednesday, September 17th. Bank of America decreased their target price on Procter & Gamble from $180.00 to $174.00 and set a “buy” rating on the stock in a report on Wednesday, October 8th. Weiss Ratings reaffirmed a “hold (c)” rating on shares of Procter & Gamble in a report on Monday, December 29th. Finally, Wells Fargo & Company decreased their price objective on shares of Procter & Gamble from $170.00 to $158.00 and set an “overweight” rating on the stock in a report on Monday. Thirteen analysts have rated the stock with a Buy rating and ten have issued a Hold rating to the company’s stock. According to MarketBeat.com, the stock presently has a consensus rating of “Moderate Buy” and an average price target of $170.81.
Insider Transactions at Procter & Gamble
In other Procter & Gamble news, CAO Matthew W. Janzaruk sold 725 shares of the business’s stock in a transaction dated Thursday, October 30th. The shares were sold at an average price of $149.57, for a total value of $108,438.25. Following the completion of the sale, the chief accounting officer owned 979 shares of the company’s stock, valued at $146,429.03. The trade was a 42.55% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available at the SEC website. 0.20% of the stock is owned by corporate insiders.
Procter & Gamble Stock Performance
NYSE:PG opened at $139.98 on Wednesday. The stock has a 50 day simple moving average of $145.48 and a 200 day simple moving average of $151.87. The stock has a market cap of $327.08 billion, a P/E ratio of 20.43, a PEG ratio of 4.73 and a beta of 0.39. Procter & Gamble Company has a 1-year low of $138.14 and a 1-year high of $179.99. The company has a current ratio of 0.71, a quick ratio of 0.51 and a debt-to-equity ratio of 0.46.
Procter & Gamble (NYSE:PG – Get Free Report) last posted its quarterly earnings data on Friday, October 24th. The company reported $1.99 earnings per share for the quarter, topping the consensus estimate of $1.90 by $0.09. Procter & Gamble had a return on equity of 32.63% and a net margin of 19.74%.The firm had revenue of $22.39 billion for the quarter, compared to analysts’ expectations of $22.23 billion. During the same quarter last year, the business earned $1.93 EPS. The company’s quarterly revenue was up 3.0% compared to the same quarter last year. Procter & Gamble has set its FY 2026 guidance at 6.830-7.100 EPS. Research analysts anticipate that Procter & Gamble Company will post 6.91 earnings per share for the current year.
Procter & Gamble Announces Dividend
The firm also recently disclosed a quarterly dividend, which was paid on Monday, November 17th. Shareholders of record on Friday, October 24th were paid a $1.0568 dividend. The ex-dividend date was Friday, October 24th. This represents a $4.23 annualized dividend and a yield of 3.0%. Procter & Gamble’s payout ratio is 61.75%.
More Procter & Gamble News
Here are the key news stories impacting Procter & Gamble this week:
- Positive Sentiment: Q1 showed an earnings beat driven by pricing and productivity, and management set FY2026 EPS guidance (6.83–7.10), supporting cash flow and the dividend; that underpins the stock’s defensive appeal. Procter & Gamble Delivers, But Is Volume Growth Still a Worry?
- Neutral Sentiment: Options flow has picked up, indicating increased trader positioning and hedging activity; this shows engagement but isn’t a clear directional signal on fundamentals. Unpacking the Latest Options Trading Trends in Procter & Gamble
- Neutral Sentiment: PG is repeatedly mentioned in analyst/market roundups (Zacks, Yahoo) as a major consumer-staples name — coverage keeps the story visible but hasn’t produced a new catalyst. Top Stock Reports for Meta, Bank of America & Procter & Gamble The Zacks Analyst Blog
- Negative Sentiment: Wells Fargo cut its price target from $170 to $158 (but kept an overweight rating) — the downgrade narrows perceived upside and can prompt profit-taking or caution among investors. Wells Fargo Adjusts Price Target on Procter & Gamble
- Negative Sentiment: Analysts and media note persistent volume weakness (especially in North America) and that the consumer staples sector has lagged the market; PG’s premium valuation vs. peers raises sensitivity to any slowdown in volume/consumption. 3 Dividend Stocks to Double Up On Right Now 5 Under-the-Radar Consumer Staples Stocks with Pricing Power (mentions PG valuation)
Procter & Gamble Company Profile
Procter & Gamble (NYSE: PG) is a multinational consumer goods company headquartered in Cincinnati, Ohio. Founded in 1837 by William Procter and James Gamble, P&G has grown into one of the world’s largest producers of branded consumer packaged goods. The company focuses on developing, manufacturing and marketing a broad portfolio of household and personal care products sold to consumers and retailers worldwide.
P&G’s product offering spans several core business categories, including Beauty, Grooming, Health Care, Fabric & Home Care, and Baby, Feminine & Family Care.
Featured Articles
- Five stocks we like better than Procter & Gamble
- Elon Taking SpaceX Public! $100 Pre-IPO Opportunity!
- Do not delete, read immediately
- This stock gets a 94 out of 100
- Punch these codes into your ordinary brokerage account
- Ticker Revealed: Pre-IPO Access to “Next Elon Musk” Company
Want to see what other hedge funds are holding PG? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Procter & Gamble Company (The) (NYSE:PG – Free Report).
Receive News & Ratings for Procter & Gamble Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Procter & Gamble and related companies with MarketBeat.com's FREE daily email newsletter.
